查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2000749

放射治疗设备市场：按产品类型、放射类型、应用和最终用户划分 - 全球市场预测 2026-2032

Radiation Therapy Equipment Market by Product Type, Radiation Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，放射治疗设备市场价值将达到 75.9 亿美元，到 2026 年将成长至 81.4 亿美元，到 2032 年将达到 127 亿美元，复合年增长率为 7.63%。

主要市场统计数据
基准年 2025 75.9亿美元
预计年份：2026年 81.4亿美元
预测年份 2032 127亿美元
复合年增长率 (%) 7.63%

简要介绍正在重组放射治疗设备采购和部署的临床、技术和营运协同因素。

在放射治疗领域，影像技术、治疗计画演算法和照射平台的进步正推动着技术的不断改进和临床应用的整合。医疗机构优先采用能够提高治疗精度、缩短治疗时间并与多学科诊疗路径整合的设备。随着医疗服务模式转向价值导向模式，临床团队所需的设备不仅要满足严格的疗效和安全性标准，还要能够简化工作流程并提升病患体验。在资金分配更加严格和监管力度加大的情况下，策略采购决策越来越重视设备的可维护性、互通性以及在整个生命週期内可证实的临床效益。

自适应成像、紧凑型放射治疗平台、人工智慧驱动的规划以及服务弹性如何全面重塑临床路径和采购重点。

多项变革正在重塑放射治疗生态系统，并影响治疗的规划、实施和评估方式。首先，影像引导和自适应放射治疗工作流程的成熟，使得高度个人化的治疗成为可能，能够根据治疗过程中解剖结构的变化进行调整，从而改变了对设备的要求，并提高了对整合成像功能的需求。其次，紧凑型、成本优化的平台的出现，扩大了本地医疗机构的覆盖范围，同时也促进了基于资本成本、服务模式和总体拥有成本（TCO）的竞争。

评估近期定价政策对营运的影响，以及供应多元化和在地化服务策略如何减轻采购中断的影响。

贸易政策调整带来的新关税措施，为医疗服务提供者和技术供应商带来了一系列营运方面的考量。对某些零件和整套放射治疗系统征收进口关税，可能会增加海外製造设备或依赖国际采购子系统的设备的购买成本。为此，采购团队正在重新评估总体拥有成本 (TCO) 的运算方法，并更加重视模组化架构，以实现分阶段升级、本地维护和零件相容性，从而降低跨境价格波动的影响。

将技术模式、医疗保健服务环境和临床应用连结起来的关键细分见解：优先考虑投资和营运规划。

了解技术、终端用户和应用领域的细分情况，可以为评估产品开发优先顺序和部署路径提供系统性的观点。从技术角度来看，诸如近距离放射（区分高剂量率和低剂量率方法）、线性加速器（区分高能量和低能配置）、质子治疗和立体定位放射治疗系统等治疗方式，各自展现出独特的临床权衡和资本成本特征。这些技术差异不仅影响临床适应症的适用性，还影响屏蔽、影像整合和面积等基础设施要求，最终影响部署计划和多学科协作需求。

美洲、欧洲、中东和非洲以及亚太地区的区域报销机制、基础设施投资和服务网路如何影响设备部署和伙伴关係模式？

区域趋势正在影响全球部署模式、监管路径和伙伴关係模式。在美洲，医保报销框架、先进癌症中心的集中以及医院系统整合的趋势，正在推动对能够处理复杂适应症的高扩充性、高通量平台的需求。快速回应服务网路和设备故障也是该地区的关键考量因素，影响供应商的选择和售后市场策略。

竞争格局分析，展示了技术整合、服务模式和临床伙伴关係如何定义供应商差异化和采购标准。

设备供应商之间的竞争动态日益取决于技术差异化、卓越服务以及临床证据的协作创造。领先的供应商正投资于互通性框架、云端规划解决方案和自适应交付能力，以提供超越硬体本身的综合提案主张。与学术机构和临床网路的伙伴关係正在加速检验研究，并将技术优势转化为指南层级的临床实践。服务模式也不断演进，包括基于结果的维护合约和性能保证，将供应商的奖励与医疗机构的运作和处理能力目标挂钩。

为医疗保健领导者提供实用建议，以协调采购、培训和服务策略与临床目标和营运弹性。

产业领导者应采取多管齐下的策略，使技术投资与临床目标和财务限制保持一致。首先，优先选择提供模组化升级路径和开放互通性的平台，以保护资本投资并简化与电子健康记录和影像系统的整合。其次，投资于培训倡议，以提升物理学家、剂量师和放射线治疗的技能，使他们能够充分利用自动化、自适应计划和立体定位放射治疗功能，从而最大限度地提高治疗能力和患者安全。第三，协商服务合同，强调可衡量的正常运转率保证、可预测的备件供应和本地技术人员认证，以降低生命週期内的不确定性。

为了确保研究结果的可重复性，我们采用了一种透明的混合方法研究途径，结合了临床文献回顾、相关人员访谈和仪器性能分析。

本分析的研究结合了对同行评审的临床文献、监管文件、技术白皮书和仪器性能报告的系统性回顾，以及对临床医生、医学物理学家、采购经理和服务经理的定向访谈。研究将定性发现与仪器规格、已发表的临床试验结果和已记录的服务模式进行关联，从而全面了解仪器的技术能力和操作限制。研究特别关注了近期关于自适应放射治疗、立体定位放射治疗技术和粒子束治疗结果的同行评审证据，以便将仪器的功能置于既定的临床路径中进行解读。

简洁扼要的结论强调，为了在癌症治疗方面取得持续进步，需要平衡临床创新、生命週期经济性和服务韧性。

总之，放射治疗设备的采购和部署正处于一个转折点，需要在技术进步、操作实用性和长期可维护性之间取得平衡。影像导引治疗、自适应计画和小型化照射系统的进步为改善临床疗效和病患体验提供了明确的机会。然而，要实现这些益处，需要采购委员会、临床团队和服务机构密切合作，以管理资金、培训和监管要求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：放射治疗设备市场：依产品类型划分

  • 外部照射装置
    • 直线加速器
    • 立体定位放射治疗系统
    • 螺旋断层放射治疗系统
    • 机器人放射外科系统
  • 近距离放射治疗装置（近距离放射治疗）

第九章：按放射类型分類的放射治疗设备市场

  • 光子束
  • 质子束
  • 电子束
  • 中子束
  • 同位素辐射
  • α粒子/β粒子

第十章 放射治疗设备市场：依应用领域划分

  • 大脑和神经系统
  • 乳癌
  • 肺
  • 摄护腺
  • 子宫颈癌/妇科癌症
  • 胃肠道癌症

第十一章：放射治疗设备市场：依最终用户划分

  • 门诊手术中心
  • 癌症研究中心
  • 医院

第十二章：放射治疗设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：放射治疗设备市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：放射治疗设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国放射治疗设备市场

第十六章 中国放射治疗设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Siemens Healthineers AG
  • Elekta AB
  • GE HealthCare Technologies Inc.
  • Ion Beam Applications SA
  • Hitachi, Ltd.
  • RefleXion Medical, Inc.
  • Nordion by Sotera Health LLC
  • Mevion Medical Systems, Inc.
  • Bionix LLC
  • Accuray Incorporated
  • Allengers Medical Systems Ltd
  • BEBIG Medical GmbH
  • BrainLab AG
  • Canon Inc.
  • Carl Zeiss AG
  • China Isotope & Radiation Corporation
  • Eckert and Ziegler AG
  • IntraOp Medical Corp.
  • Klarity Medical & Equipment（GZ）Co., Ltd.
  • Koninklijke Philips NV
  • LINEV Group
  • MinXray, Inc.
  • Mitsubishi Heavy Industries, Ltd.
  • Oraya Therapeutics Inc.
  • PTW Freiburg GmbH
  • Stryker Corporation
  • Sumitomo Heavy Industries, Ltd.
  • Xstrahl Group
Product Code: MRR-02026C4C95C5

The Radiation Therapy Equipment Market was valued at USD 7.59 billion in 2025 and is projected to grow to USD 8.14 billion in 2026, with a CAGR of 7.63%, reaching USD 12.70 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.59 billion
Estimated Year [2026] USD 8.14 billion
Forecast Year [2032] USD 12.70 billion
CAGR (%) 7.63%

A concise introduction framing the converging clinical, technological, and operational forces reshaping radiation therapy equipment procurement and adoption

The radiation therapy landscape is undergoing a period of concentrated technical refinement and clinical integration, driven by advances in imaging, planning algorithms, and delivery platforms. Providers are prioritizing equipment that improves precision, reduces treatment times, and integrates with multidisciplinary care pathways. As care delivery shifts toward value-based models, clinical teams require devices that not only meet stringent efficacy and safety standards but also enable workflow efficiencies and patient experience improvements. Amidst tighter capital allocation and heightened regulatory scrutiny, strategic procurement decisions increasingly weigh lifecycle serviceability, interoperability, and demonstrable clinical benefit.

Concurrently, research programs and academic centers continue to push modality boundaries, exploring dose escalation strategies, adaptive treatment approaches, and the therapeutic potential of novel particles. This research momentum is complemented by a more informed patient population and referring physicians who expect clear evidence of outcomes and toxicity mitigation. Given these dynamics, executives and clinical leaders must synthesize technological capability with operational readiness and reimbursement realities when evaluating upgrades or new installations. Clear alignment between clinical goals and equipment selection will determine whether institutions maximize clinical outcomes while preserving financial sustainability.

How adaptive imaging, compact delivery platforms, AI-enabled planning, and service resilience are collectively reshaping clinical pathways and procurement priorities

Several transformative shifts are redefining the radiation therapy ecosystem and the way care is planned, delivered, and evaluated. First, the maturation of image-guided and adaptive radiotherapy workflows enables highly personalized treatments that adjust to anatomical changes across a course of care, thus altering equipment requirements and demand for integrated imaging capability. Second, the emergence of compact and cost-optimized platforms expands access to community settings while stimulating competition based on service models and total cost of ownership rather than capital price alone.

Third, computational advances-most notably in treatment planning automation and AI-assisted contouring-are changing workforce skill mixes and highlight the need for vendors to provide software updates and validation frameworks. Fourth, patient-centric design and reduced fractionation regimens are increasing throughput expectations, pushing institutions to balance speed with precision. Lastly, supply chain resilience and aftermarket service strategies have taken on heightened importance as providers prioritize uptime and predictable maintenance costs. Together, these shifts compel stakeholders to re-evaluate clinical pathways, procurement criteria, and vendor partnerships to remain clinically relevant and operationally efficient.

Assessing the operational consequences of recent tariff policies and how supply diversification and local servicing strategies can mitigate procurement disruption

The introduction of new tariff measures originating from trade policy adjustments has introduced a cascade of operational considerations for healthcare providers and technology suppliers. Import duties on select components and finished radiotherapy systems have the potential to raise acquisition costs for equipment that is manufactured abroad or reliant on internationally sourced subsystems. In response, procurement teams are reassessing total cost of ownership calculations and placing greater emphasis on modular architectures that permit phased upgrades, local serviceability, and parts interchangeability to mitigate exposure to cross-border price volatility.

Manufacturers and distributors are adapting by diversifying supplier networks, localizing final assembly where feasible, and renegotiating service contracts to preserve predictable lifecycle economics for customers. Clinical planners and capital committees must therefore anticipate longer lead times for certain configurations and prioritize compatibility with existing infrastructure to avoid costly retrofits. On the positive side, tariffs can accelerate strategies that strengthen domestic manufacturing capabilities and aftermarket ecosystems, creating opportunities for localized maintenance hubs and training programs. Ultimately, the cumulative impact of these trade measures will be felt across procurement timelines, vendor selection frameworks, and long-term maintenance planning, requiring coordinated responses from clinical, financial, and supply chain stakeholders.

Key segmentation insights linking technology modalities, healthcare delivery settings, and clinical applications to prioritize investments and operational planning

Understanding segmentation across technology, end user, and application provides a structured lens to evaluate product development priorities and adoption pathways. When technologies are considered, modalities such as brachytherapy-distinguishing high dose rate and low dose rate approaches-alongside linear accelerators differentiated by high energy and low energy configurations, proton therapy, and stereotactic systems each present distinct clinical trade-offs and capital profiles. These technology distinctions influence not only clinical indication suitability but also infrastructure requirements such as shielding, imaging integration, and room footprint, which in turn affect deployment timelines and multidisciplinary coordination requirements.

From an end user perspective, ambulatory surgical centers-comprising both hospital-affiliated centers and standalone centers-operate under different staffing, reimbursement, and throughput models compared with cancer research centers, which are further categorized into government research institutes and private research institutes, and hospitals, where private hospitals and public hospitals have divergent procurement governance and budget cycles. These differences shape purchase considerations, service level expectations, and training investments. Application segmentation across disease sites such as brain and nervous system treatments, where conventional radiotherapy and stereotactic radiosurgery play distinct roles, breast cancer managed via external beam and intraoperative strategies, lung cancer treated with external beam and stereotactic body radiotherapy, and prostate cancer approached through brachytherapy and external beam modalities, clarifies clinical workflow impacts and device feature priorities. Mapping technologies to end users and applications reveals where integration, clinical evidence generation, and specialized service support are most needed to drive adoption and optimize patient outcomes.

How regional reimbursement, infrastructure investment, and service networks across the Americas, Europe Middle East & Africa, and Asia-Pacific shape equipment adoption and partnership models

Regional dynamics influence adoption patterns, regulatory pathways, and partnership models across the globe. In the Americas, reimbursement frameworks, high concentration of advanced cancer centers, and a trend toward consolidations among hospital systems drive demand for scalable, high-throughput platforms that support complex indications. This region also places a premium on service networks and rapid response for equipment downtime, which shapes vendor selection and aftermarket strategies.

Across Europe, the Middle East & Africa, diverse regulatory landscapes and variable infrastructure investment levels result in a heterogeneous adoption curve where high-income markets prioritize cutting-edge modalities and lower-resource settings focus on cost-effective, durable platforms with strong local service support. Cross-border regulatory harmonization efforts and regional centers of excellence facilitate knowledge transfer and collaborative clinical trials. In the Asia-Pacific region, robust capital investment in cancer care combined with a growing number of privately funded hospitals and research centers propels demand for both advanced modalities and compact systems that can be deployed in tiered healthcare settings. Local manufacturing initiatives and public-private partnerships further influence procurement decisions. These regional patterns underscore the need for flexible commercial strategies that adapt to reimbursement realities, infrastructure constraints, and long-term training commitments.

Competitive landscape analysis showing how technology integration, service models, and clinical partnerships define vendor differentiation and procurement criteria

Competitive dynamics among equipment providers are increasingly defined by a combination of technological differentiation, service excellence, and collaborative clinical evidence generation. Leading vendors invest in interoperability frameworks, cloud-enabled planning solutions, and adaptive delivery capabilities to offer an integrated value proposition that extends beyond the hardware. Partnerships with academic centers and clinical networks accelerate validation studies and help translate technological advantages into guideline-level clinical practice. Service models have evolved to include outcome-based maintenance contracts and performance guarantees that align vendor incentives with institutional uptime and throughput targets.

Smaller and niche suppliers focus on specialized modalities or retrofit solutions that extend the life of installed bases, while larger global corporations emphasize scale, regulatory experience, and expansive service footprints. Strategic acquisitions and alliances continue to be a lever for filling capability gaps, particularly in software, imaging, and particle therapy domains. For purchasers, vendor evaluation now prioritizes lifecycle support, credentialed training programs, and transparent roadmaps for software updates and regulatory compliance. These competitive behaviors create an environment where differentiation is measured by demonstrable clinical impact, predictable service economics, and the ability to integrate into complex hospital IT and imaging ecosystems.

Actionable recommendations for healthcare leaders to align procurement, training, and service strategies with clinical goals and operational resilience

Industry leaders should adopt a multi-pronged strategy to align technological investments with clinical objectives and fiscal constraints. First, prioritize platforms that offer modular upgrade paths and open interoperability to protect capital investments and simplify integration with electronic health records and diagnostic imaging systems. Second, invest in training initiatives that upskill physicists, dosimetrists, and therapists to fully leverage automation, adaptive planning, and stereotactic delivery capabilities, thereby maximizing throughput and patient safety. Third, negotiate service agreements that emphasize measurable uptime commitments, predictable spare parts availability, and local technician certification to reduce lifecycle uncertainty.

Additionally, stakeholders should pursue partnerships with research centers to co-develop protocols and real-world evidence that support new indications and reimbursement discussions. Emphasize pilot programs that validate clinical and operational benefits in situ before large-scale rollouts, and incorporate risk-sharing clauses to align vendor and provider incentives. Finally, maintain active supply chain contingency planning that includes multi-sourcing of critical components and consideration of local assembly or maintenance hubs to minimize exposure to global trade disruptions. By implementing these measures, organizations can enhance clinical outcomes while protecting financial resilience and operational continuity.

A transparent mixed-methods research approach combining clinical literature review, stakeholder interviews, and device performance analysis to ensure reproducible insights

The research underpinning this analysis combined a systematic review of peer-reviewed clinical literature, regulatory filings, technical white papers, and device performance reports with targeted interviews of clinicians, medical physicists, procurement leads, and service managers. Qualitative insights were triangulated with equipment specifications, published clinical trial outcomes, and documented service models to ensure a comprehensive understanding of both technological capabilities and operational constraints. Particular attention was paid to recent peer-reviewed evidence on adaptive radiotherapy, stereotactic techniques, and particle therapy outcomes to contextualize device capabilities within established clinical pathways.

Vendor documentation and installation case studies informed assessments of maintenance strategies and aftermarket support, while regional regulatory guidance and reimbursement policy briefings shaped the interpretation of adoption barriers. Confidential interviews provided real-world perspectives on procurement cycles, training burdens, and downtime tolerance. The methodology emphasized reproducibility and source validation, and where appropriate, findings were cross-checked against multiple independent sources to reduce bias. This mixed-methods approach yields actionable insights that balance clinical nuance with pragmatic operational considerations.

A concise conclusion emphasizing the need to balance clinical innovation, lifecycle economics, and service resilience to achieve sustainable improvements in cancer care

In conclusion, radiation therapy equipment procurement and deployment are at an inflection point where technological sophistication must be balanced with operational pragmatism and long-term serviceability. Advancements in image guidance, adaptive planning, and compact delivery systems present clear opportunities to improve clinical outcomes and patient experience. However, realizing these benefits requires deliberate alignment across procurement committees, clinical teams, and service organizations to manage capital, training, and regulatory demands.

Looking ahead, organizations that adopt modular, interoperable technologies, invest in workforce development, and negotiate robust service arrangements will be better positioned to navigate trade policy shifts and regional variances in reimbursement and infrastructure. Strategic partnerships with research institutions and a focus on generating real-world evidence will further strengthen clinical and commercial propositions. By taking a disciplined approach to technology adoption-one that integrates clinical priorities with lifecycle economics and supply chain resilience-providers can deliver higher-value care while preserving flexibility for future innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Radiation Therapy Equipment Market, by Product Type

  • 8.1. External Beam Radiation Therapy Device
    • 8.1.1. Linear Accelerators
    • 8.1.2. Stereotactic Systems
    • 8.1.3. Tomotherapy Systems
    • 8.1.4. Robotic Radiosurgery Systems
  • 8.2. Internal Beam Radiation Therapy Device (Brachytherapy)

9. Radiation Therapy Equipment Market, by Radiation Type

  • 9.1. Photon Beam
  • 9.2. Proton Beam
  • 9.3. Electron Beam
  • 9.4. Neutron Beam
  • 9.5. Isotope-Based Radiation
  • 9.6. Alpha / Beta Particle

10. Radiation Therapy Equipment Market, by Application

  • 10.1. Brain And Nervous System
  • 10.2. Breast
  • 10.3. Lung
  • 10.4. Prostate
  • 10.5. Cervical / Gynecological Cancer
  • 10.6. Gastrointestinal Cancer

11. Radiation Therapy Equipment Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cancer Research Centers
  • 11.3. Hospitals

12. Radiation Therapy Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Radiation Therapy Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Radiation Therapy Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Radiation Therapy Equipment Market

16. China Radiation Therapy Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Siemens Healthineers AG
  • 17.6. Elekta AB
  • 17.7. GE HealthCare Technologies Inc.
  • 17.8. Ion Beam Applications S.A.
  • 17.9. Hitachi, Ltd.
  • 17.10. RefleXion Medical, Inc.
  • 17.11. Nordion by Sotera Health LLC
  • 17.12. Mevion Medical Systems, Inc.
  • 17.13. Bionix LLC
  • 17.14. Accuray Incorporated
  • 17.15. Allengers Medical Systems Ltd
  • 17.16. BEBIG Medical GmbH
  • 17.17. BrainLab AG
  • 17.18. Canon Inc.
  • 17.19. Carl Zeiss AG
  • 17.20. China Isotope & Radiation Corporation
  • 17.21. Eckert and Ziegler AG
  • 17.22. IntraOp Medical Corp.
  • 17.23. Klarity Medical & Equipment (GZ) Co., Ltd.
  • 17.24. Koninklijke Philips N.V.
  • 17.25. LINEV Group
  • 17.26. MinXray, Inc.
  • 17.27. Mitsubishi Heavy Industries, Ltd.
  • 17.28. Oraya Therapeutics Inc.
  • 17.29. PTW Freiburg GmbH
  • 17.30. Stryker Corporation
  • 17.31. Sumitomo Heavy Industries, Ltd.
  • 17.32. Xstrahl Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RADIATION THERAPY EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TOMOTHERAPY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TOMOTHERAPY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TOMOTHERAPY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ROBOTIC RADIOSURGERY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ROBOTIC RADIOSURGERY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ROBOTIC RADIOSURGERY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY DEVICE (BRACHYTHERAPY), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY DEVICE (BRACHYTHERAPY), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY DEVICE (BRACHYTHERAPY), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PHOTON BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PHOTON BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PHOTON BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ELECTRON BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ELECTRON BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ELECTRON BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY NEUTRON BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY NEUTRON BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY NEUTRON BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ISOTOPE-BASED RADIATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ISOTOPE-BASED RADIATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ISOTOPE-BASED RADIATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ALPHA / BETA PARTICLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ALPHA / BETA PARTICLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ALPHA / BETA PARTICLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CERVICAL / GYNECOLOGICAL CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CERVICAL / GYNECOLOGICAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CERVICAL / GYNECOLOGICAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GASTROINTESTINAL CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GASTROINTESTINAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GASTROINTESTINAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 129. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 153. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)